CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 239 enrolled
Drug / intervention
CardioMEMS HF Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02693691
NCT02693691N/ACompleted

CardioMEMS European Monitoring Study for Heart Failure

Abbott Medical Devices·interventional·Posted Feb 29, 2016·Updated Apr 5, 2022

In Brief

A clinical study evaluating CardioMEMS HF System for Heart Failure. Completed, enrolled 239 participants across 2 sites.

Detailed Summary

The purpose of this study is to characterize the use of the CardioMEMS™ HF System when used in a real-world setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 29, 2016
Enrollment StartMay 1, 2016
Primary CompletionMar 31, 2019
Study CompletionMar 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 10.3 years ago

Interventions

CardioMEMS HF Systemdevice

Pulmonary Artery Pressure Monitoring